Biotech insanity $AVEO phase 3 OS was worse than control arm and the price still $8. Also price target Raised to $26.                                          $ATNM current price .21. relapsed or refractory AML P2 86% remission rate great results. $bmy $jnj $pfe $mrk $amgn $ABBV